Latest News

MannKind Corporation recently reported that the FDA accepted its supplemental New Drug Application for the FUROSCIX ReadyFlow Autoinjector, a rapid subcutaneous furosemide delivery device for adults with chronic heart failure or chronic kidney disease, with a PDUFA target action date of July 26, 2026. If approved, ReadyFlow could meaningfully change at-home management of fluid buildup by cutting administration time from five hours to under 10 seconds while showing bioavailability comparable...

If you are wondering whether Jackson Financial at around $105 is still good value after its huge run, or if the easier gains have already been made, this breakdown will help you size up the opportunity with a cool head. The stock has climbed 7.7% over the last week, 12.0% in the past month, and is now up 20.6% year to date and 258.8% over three years. This naturally raises questions about how much upside is left versus the risk of a pullback. Recently, investors have been paying closer...

Hamilton Insurance Group (NYSE:HG) is back in focus after fresh commentary flagged a projected 2% sales decline and a sharp earnings per share drop, highlighting weaker demand and a more fragile long term outlook. See our latest analysis for Hamilton Insurance Group. Interestingly, that softer outlook has not stopped the stock from climbing, with a 90 day share price return of 16.47% and a year to date share price return of 50.56%. This suggests momentum is still building rather than fading...

Deere (DE) just got hit from two directions at once: a softer earnings outlook and public pressure from President Donald Trump to cut equipment prices, and the stock has been feeling that squeeze. See our latest analysis for Deere. Even with the recent pullback after the earnings update and political pressure, Deere’s 15.93% year to date share price return and 11.62% one year total shareholder return suggest momentum is still broadly positive, supported by ongoing dividend payments and fresh...

In December 2025, Oruka Therapeutics announced that Board member Cameron Turtle resigned and was replaced by commercial veteran Chris Martin, who will serve as a Class II director and chair the Compensation Committee while also joining the Audit Committee. Martin’s track record in building and executing launch strategies at companies that later attracted multi-billion-dollar acquisitions highlights Oruka’s increasing focus on preparing its pipeline for potential commercialization. We’ll now...

In recent days, Williams-Sonoma has faced ongoing store closures and soft same-store sales, even as the Federal Reserve cut interest rates and expanded its balance sheet to support economic growth. This mix of internal headwinds and a more supportive monetary backdrop highlights the tension between the company’s need to adjust its strategy and improving broader market conditions. We’ll now examine how easier monetary policy, alongside Williams-Sonoma’s weaker same-store sales trends, could...

West Pharmaceutical Services (WST) has been drifting lower this year, and with the stock down about 19% year to date, investors are starting to revisit the story with a fresh valuation lens. See our latest analysis for West Pharmaceutical Services. The recent pullback has come despite steady underlying growth, with the 90 day share price return of 3.89% only partially offsetting the 18.52% year to date share price decline and softer 1 year total shareholder return of 18.67%. This suggests...

Why Ollie's latest earnings caught Wall Street's attention Ollie's Bargain Outlet Holdings (OLLI) just delivered third quarter numbers that topped profit expectations and came with a guidance bump, a combination that usually makes investors sit up and take notice. See our latest analysis for Ollie's Bargain Outlet Holdings. Even with the latest beat and a guidance raise, the stock’s recent momentum has cooled, with a roughly 16 percent 3 month share price decline. However, a solid 3 year...

Earlier in December, Philip Morris International’s board declared a regular quarterly dividend of US$1.47 per share and renewed multi‑year credit facilities totaling US$2.00 billion and €1.50 billion to support general corporate needs and working capital. Ferrari announced it has renewed and upgraded its long‑running partnership with Philip Morris International, while the company continues to emphasize smoke‑free products and reaffirmed its 2025 earnings guidance of US$7.39 to US$7.49 in...

Group 1 Automotive (GPI) has quietly delivered strong multi year returns, even as the stock has slipped about 3% over the past day and 11% over the past 3 months. That disconnect has value investors taking a closer look. See our latest analysis for Group 1 Automotive. At around $413.74, the recent pullback in Group 1 Automotive’s share price contrasts with its substantial three and five year total shareholder returns. This suggests that momentum has cooled a little, even as the longer term...

Wondering if Alstom is a quietly mispriced opportunity or a value trap in plain sight? Let us break down what the market is really implying about this stock right now. Alstom's share price has climbed 5.6% over the last week and 10.6% year to date, though it is still down 42.5% over five years, a mix that hints at shifting sentiment and fresh expectations. Recent headlines have focused on Alstom's progress on major rail and rolling stock contracts, as well as ongoing efforts to streamline...

Earlier this month, Medical Properties Trust announced a 12% dividend increase, highlighted progress in upgrading its tenant base, and authorized a US$150,000,000 share repurchase program after several years of balance sheet repair. By replacing bankrupt tenants with stronger hospital operators and signaling confidence through buybacks and higher payouts, the REIT is directly addressing prior concerns about tenant quality and dividend reliability. Now we’ll explore how this dividend hike and...

UL Solutions (ULS) just wrapped up a $975 million follow on equity offering, with former parent ULSE fully exiting its Class A stake. This secondary sale reshapes the stock’s ownership and narrative. See our latest analysis for UL Solutions. Against that backdrop, UL Solutions’ share price at $77.88 still reflects strong momentum, with a robust year to date share price return and solid one year total shareholder return. This suggests investors see durable growth despite recent secondary sale...

Cohen & Steers, Inc. recently expanded its active ETF lineup by launching the Cohen & Steers Infrastructure Opportunities Active ETF (CSIO) and the Cohen & Steers Short Duration Preferred and Income Active ETF (CSSD), both now trading on NYSE Arca and targeting infrastructure and preferred securities exposure. This move broadens the firm’s specialist real assets and alternative income platform, giving investors additional actively managed ETF options that combine Cohen & Steers’ asset-class...

Earlier this week, Barclays upgraded Pernod Ricard from “equal-weight” to “overweight,” citing the spirits group’s improved positioning in the U.S. and India alongside reduced exposure to China. The bank’s more optimistic stance emphasizes emerging benefits from India’s trade agreement with the UK and long-term opportunities linked to new consumption patterns, including ride-hailing and robotaxis in Pernod Ricard’s largest market. We’ll now examine how Barclays’ upgraded view, especially...

Tamarack Valley Energy Ltd. recently adopted a Shareholder Rights Plan, appointed former Veren Inc. CEO Craig Bryksa to its board effective December 2, 2025, and issued 2026 production guidance of 69,000–71,000 boe/d. Taken together, the rights plan and board appointment highlight a stronger focus on boardroom experience and deal oversight at a time of potential corporate interest in the company. We’ll now examine how the new Shareholder Rights Plan may influence Tamarack Valley Energy’s...

Wondering if SK hynix is still worth buying after its massive run, or if the smart move now is to wait for a better price? This article is going to unpack exactly what the current share price is really baking in. The stock has climbed 5.0% over the last week and a huge 233.5% year to date, even after a recent 6.7% pullback over the past month and a 228.8% gain over the last year. Much of this surge has ridden the wave of enthusiasm around AI infrastructure and high bandwidth memory, with SK...

AeroVironment recently reported very large year-on-year revenue growth to US$472.51 million and raised its fiscal 2026 sales outlook, even as higher integration and operational costs pushed the company into a quarterly net loss and prompted a cut to full-year profit guidance. At the same time, AeroVironment has secured multi‑year defense and security wins, including an up to US$874.26 million U.S. Army IDIQ and a US$4.8 million U.S. Coast Guard robotics contract, that reinforce its role as a...

Earlier this week, Guggenheim initiated coverage of monday.com with a positive rating, highlighting its AI capabilities and rapid growth in newer products such as CRM, Dev, and Service. The firm argued that monday.com’s broader, sales-led multi-product strategy is not yet fully reflected in how the market values the business. We’ll now examine how Guggenheim’s confidence in monday.com’s AI-driven, multi-product expansion could influence the company’s broader investment narrative. The best AI...

In recent days, VectorCare, in partnership with Lyft, launched the Lyft Smart on FHIR App for Epic’s App Market, while Lyft also advanced its AI customer support capabilities and participated in promotional and investor events, all against the backdrop of intensifying autonomous vehicle competition and a reported hit-and-run incident involving a Lyft driver. Together, these developments highlight Lyft’s push to embed its services deeper into healthcare and digital ecosystems even as...

S&P Global (SPGI) is leaning hard into enterprise AI, pairing a new multi year partnership with Google Cloud and fresh AWS integrations to push its data deeper into customers everyday workflows. See our latest analysis for S&P Global. The steady drumbeat of AI partnerships and fresh debt issuance has not yet translated into a breakout move, with the share price at $501.03 and a roughly flat 1 year total shareholder return. However, a strong 3 year total shareholder return suggests the long...

Jabil (JBL) just got caught in the latest market rotation, sliding after investors stepped back from AI exposed manufacturers. But that pullback is colliding with a busy stretch of operational and governance developments. See our latest analysis for Jabil. Despite the latest 5.1% one day share price drop to about $222, Jabil still shows strong momentum, with a roughly mid 50s year to date share price return and a powerful multi year total shareholder return above 400%. This suggests investors...

In early December 2025, Huntington Bancshares reduced its prime rate from 7% to 6.75%, following an earlier cut in October, and its board has declared a US$356.25 per-share quarterly dividend on its 5.70% Series I Non-Cumulative Perpetual Preferred Stock, payable in March 2026. This prime rate cut directly lowers borrowing costs for customers on variable-rate products and offers fresh insight into how Huntington is positioning its balance sheet and loan growth priorities amid changing...

Microchip Technology (MCHP) just nudged its December quarter outlook higher, now aiming for about 1% sequential sales growth and roughly 12% revenue growth year over year, helped by demand tied to AI friendly data center products. See our latest analysis for Microchip Technology. The upgraded outlook comes after a run of upbeat catalysts, including new ultra efficient power monitors and upcoming tech conference appearances. Investors have noticed, with a strong 1 month share price return of...